Search earnings tickers

GILD

2024Q2AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2024-08-08 · Fiscal end 2024-06-30 · Features as of 2024-08-08

← Earnings history

Street

Consensus EPS1.60

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.4%

IV front—

P/C full—

P/C front—

Features as of2024-08-08

Run-up

Close—

Ret 5d-1.2%

Ret 10d-1.2%

Ret 20d+8.0%

Ret 30d+9.1%

Print

Actual EPS

2.01Beat

Estimated EPS1.60

Actual revenue

7.0B

Surprise %+25.6%

Beat / missBeat

Beat streak 42

Beat streak 82

Reaction

1-day stock reaction-1.7%

Implied vs actual

Implied 2.4%Actual 0.9%

Gap reaction-0.9%

Day result-2.6%

Next-day upNo

Realized / IV0.37×

Post tape

Post 5d+0.2%

Post 10d+4.2%

Post volume9.5M

Vol ×10d1.54×

Vol ×20d1.47×

Post range4.6%